Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Cathelicidin in COPD
NCT05431218Phase 4Completed
- Sponsor
- Karaganda Medical University
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label trial of vitamin d in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Karaganda Medical University. Primary endpoints: Dynamics of vitamin D levels at 6 months and Dynamics of cathelicidin levels at 6 months. Started Feb 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05431218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05431218.